Due to the difficulty in replicating GSK's inhalation device, there is not yet any FDA-approved generic for Advair, but TEVA has submitted a 505b2 NDA for a (non-substitutable) Advair knockoff.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.